Consent Decree ‘Unnecessary’ But Still Scilabs Nutraceuticals’ High Road For GMP Compliance
This article was originally published in The Tan Sheet
Executive Summary
SciLabs Nutraceuticals agrees to a decree that closes its manufacturing operations despite the agency not responding to “numerous requests” to work with the firm on its GMP compliance, says CEO Paul Edalat. Another firm, Raw Deal, also agreed to an offer from FDA and DoJ, but its owner faces incarceration.